BOYS, MARK LAURENCE,DELISLE, ROBERT KIRK,HICKEN, ERIK JAMES,KENNEDY, APRIL L.,MARESKA, DAVID A.,MARMSATER, FREDRIK P.,MUNSON, MARK C.,NEWHOUSE, BRAD,RAST, BRYSON,RIZZI, JAMES P.,RODRIGUEZ, MARTHA E.,T
申请号:
SG2013045349
公开号:
SG191129A1
申请日:
2011.12.13
申请国别(地区):
SG
年份:
2013
代理人:
摘要:
Compounds of Formula I: and pharmaceutically acceptable salts thereof in which R1, R2, R3, R4, R5 and R6 have the meanings given in the specification, are inhibitors of cFMS and are useful in the treatment of fibrosis, bone-related diseases, cancer, autoimmune disorders, inflammatory diseases, cardiovascular diseases, pain and burns in a mammal.